Materials & Techniques Flashcards
7 cards from real FAC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Materials & Techniques flashcards as text
Which cannula tip design is preferred to minimize the risk of intravascular injection compared to sharp needles?
Answer: Blunt-tip microcannula
Blunt-tip microcannulas deflect off vessel walls rather than piercing them, substantially reducing the likelihood of intravascular filler placement.
The recommended injection depth for treating nasolabial folds with a high-G' HA filler is typically:
Answer: Subcutaneous
Nasolabial folds are best addressed subcutaneously, where the filler can volumize the underlying tissue without creating a visible ridge in the skin.
When performing a thread lift with PCL (polycaprolactone) threads, the primary long-term advantage over PDO threads is:
Answer: Longer duration due to slower degradation (up to 2 years)
PCL degrades more slowly than PDO, maintaining its structural support and collagen-stimulating effect for up to 18–24 months.
Lidocaine is commonly added to HA filler preparations to:
Answer: Reduce patient discomfort during injection
Pre-mixed lidocaine in HA formulations provides in-situ analgesia, improving patient comfort without affecting the filler's volumizing properties.
The retrograde linear threading technique involves:
Answer: Depositing filler as the needle is withdrawn along the treatment path
In retrograde threading, product is released during needle withdrawal, creating an even column of filler along the desired plane.
Which filler material is most appropriate for periosteal placement to restore malar (cheekbone) projection?
Answer: High-G' HA or CaHA filler
Deep supraperiosteal placement requires a firm, high-G' product or CaHA to provide structural lift and project the malar complex effectively.
Hyaluronidase dissolves HA filler by cleaving:
Answer: Glucosaminidic bonds within the HA polysaccharide chain
Hyaluronidase is a hydrolase enzyme that cleaves the beta-1,4 glucosaminidic bonds of the HA backbone, breaking down both native and cross-linked HA.